A retrospective study was conducted to examine the clinical features a
nd outcome of 31 adult pneumococcal meningitis patients during the yea
rs 1981-92, The incidence was 1.0/100,000 adults/year. The case fatali
ty rate was 16% (5/31), and in patients older than 70 years, 33% (3/9)
, Sequelae were seen in 29% (7/24), mostly otoneurologic symptoms. In
27/28 bacterial isolates the serotypes found were included in the 23-v
alent unconjugated polysaccharide vaccine in current use, All 28 isola
tes were fully sensitive to penicillin. 49/51 non-meningitis blood iso
lates had MIC values less than or equal to 0.06 mg/l, 2 isolates had M
IC values of 0.125 mg/l and 0.25 mg/l, and 50/50 were serotypes includ
ed in the 23-valent vaccine. Pneumococcal meningitis is a disease caus
ing considerable mortality and morbidity. The relatively low case fata
lity rate found in the present study may be due to the patients' good
health prior to admission, rapid specific microbiological diagnosis, a
bsence of penicillin-resistant pneumococci among the meningitis strain
s, and immediate institution of specific and supportive therapy.